Reduction in human papillomavirus vaccine type prevalence among young women screened for cervical cancer in an integrated US healthcare delivery system in 2007 and 2012-2013

Journal of Infectious Diseases

Volumn 212, Issue 12, 2015, Pages 1970-1975

  Dunne, Eileen F ^a   Naleway, Allison ^c   Smith, Ning ^c   Crane, Bradley ^c   Weinmann, Sheila ^c   Braxton, Jim ^a   Steinau, Martin ^b   Unger, Elizabeth R ^b   Markowitz, Lauri E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

HPV; HPV type prevalence; Impact; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER SCREENING; CHLAMYDIA; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INTEGRATED HEALTH CARE SYSTEM; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; VIRUS DETECTION; CLASSIFICATION; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VIROLOGY; YOUNG ADULT;

ADULT; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POLYMERASE CHAIN REACTION; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 84959418864     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv342     Document Type: Article

References (13)

1. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63(RR-05):1-30.
2. Markowitz LE, Hariri S, Unger ER, et al. Post-licensure monitoring of HPV vaccine in the United States. Vaccine 2010; 28:4731-7.
3. Hariri S, Markowitz LE, Dunne EF, Unger ER. Population impact of HPV vaccines: summary of early evidence. J Adol Health 2013; 53:679-82.
4. Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillo-mavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Survey 2003-2010. J Infect Dis 2013; 208: 385-93.
5. Kahn JA, Brown DR, Ding L, et al. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics 2012; 130:249-56.
6. Cummings T, Zimmet GD, Brown D, et al. Reduction of HPV infections through vaccination among at-risk urban adolescents. Vaccine 2012; 30:5496-9.
7. Dunne EF, Klein NP, Naleway AL, et al. Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact. Cancer Causes Control 2013; 24:403-7.
8. Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. J Infect Dis 2011; 204: 566-73.
9. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-27.
10. Malagón T, Drolet M, Boily MC, et al. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:781-9.
11. Williams WW, Peng-Jun L, O'Halloran A, et al. Vaccination coverage among adults, excluding influenza vaccination-United States, 2013. MMWR Morb Mortal Wkly Rep 2015; 64: 95-102.
12. Mesher D, Soldan K, Howell-Jones R, et al. Reduction in HPV 16/18 in sexually active young women following the introduction of HPV immunization in England. Vaccine 2013; 32:26-32.
13. Tabrizi SN, Brotherton JM, Kaldor JM, et al. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Lancet Infect Dis 2014; 10:958-66.